Journals / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 2

Hemodynamic efects of atrial natriuretic peptide in ischemia-reperfusion injury that occurs afer exercise

Pages
298–305
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hemodynamic diference was not observedbetween groups given the same amount of isatin before ANP.Conclusion: Tis study indicated that higher ANP concentrations before ischemia were more efective on the lef ventricle contractilityand relaxation functions in the hearts that were exposed to exercise.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes.We compared the hemodynamic efects of ANP and isatin, which is known as an ANP receptor blocker, in ischemia followed byreperfusion in exercised rat hearts with nonexercised ones.Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups afer a running protocol for 5 days and 4 nonexercised(NE) groups.
📊
Key Findings & Data:In the secondprotocol, diferent doses of isatin (0.1, 10, 100 µM/L) were added to the perfusion solution before ANP in 3 E and 3 NE groups.
💡
Conclusion & Impact:Hemodynamic diference was not observedbetween groups given the same amount of isatin before ANP.Conclusion: Tis study indicated that higher ANP concentrations before ischemia were more efective on the lef ventricle contractilityand relaxation functions in the hearts that were exposed to exercise.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes.We compared the hemodynamic efects of ANP and isatin, which is known as an ANP receptor blocker, in ischemia followed byreperfusion in exercised rat hearts with nonexercised ones.Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups afer a running protocol for 5 days and 4 nonexercised(NE) groups. In the frst protocol, ANP was added to the perfusion solution before ischemia in an E and NE group. In the secondprotocol, diferent doses of isatin (0.1, 10, 100 µM/L) were added to the perfusion solution before ANP in 3 E and 3 NE groups. Lefventricular developed pressure (LVDP) and maximum and minimum rates of change in lef ventricular pressure (dP/dtmax and dP/dtmin) were recorded.Results: Higher LVDP and dP/dtmin values were observed in the E group than the NE group following addition of ANP before ischemia.Values of dP/dtmax were higher in the E group at the frst minute of reperfusion period. Hemodynamic diference was not observedbetween groups given the same amount of isatin before ANP.Conclusion: Tis study indicated that higher ANP concentrations before ischemia were more efective on the lef ventricle contractilityand relaxation functions in the hearts that were exposed to exercise.

🔖

Cite This Article

SÜT, N., GÜREL, E. E., VARDAR, S. A., KARADAĞ, Ç. H., TOPUZ, R. D., PALABIYIK, O., ÇALIŞKAN, S., TOPÇU, S. Ö. (2022). Hemodynamic efects of atrial natriuretic peptide in ischemia-reperfusion injury that occurs afer exercise. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 2, 298–305. https://ajindex.com/articles/610924

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Clerico A. Vittorini S. Te cardiac natriuretic hormone system. In: Clerico A, Emdin M, editors. Natriuretic Peptides: Te Hormones of the Heart. Trento, Italy: Springer-Verlag Italia; 2006. pp. 21–64
  2. Raine AE, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533–537
  3. Karakuşoğlu Ö, Vardar SA, Kunduracılar H, Süt N. Efects of short duration supramaximal exercise on plasma atrial natriuretic peptide concentrations in healthy subjects. Turkiye Klinikleri J Sports Sci 2010; 2: 1–6
  4. Mandroukas K, Zakas A, Aggelopoulou N, Christoulas K, Abatzides G, Karamouzis M. Atrial natriuretic factor responses to submaximal and maximal exercise. Br J Sports Med 1995; 29: 248–251
  5. Onuoha GN, Nicholls DP, Patterson A, Beringer T. Neuropeptide secretion in exercise. Neuropeptides 1998; 32: 319–325
  6. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012; 59: 969–978
  7. Wakui S, Sezai A, Tenderich G, Hata M, Osaka S, Taniguchi Y, Koerfer R, Minami K. Experimental investigation of direct myocardial protective efect of atrial natriuretic peptide in cardiac surgery. J Torac Cardiovasc Surg 2010; 139: 918–925
  8. Yang XM, Philipp S, Downey JM, Cohen MV. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 2006; 101: 311–318
  9. Kasama S, Furuya M, Toyama T, Ichikawa S, Kurabayashi M. Efect of atrial natriuretic peptide on lef ventricular remodelling in patients with acute myocardial infarction. Eur Heart J 2008; 29: 1485–1494
  10. Sangawa K, Nakanishi K, Ishino K, Inoue M, Kawada M, Sano S. Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart. Ann Torac Surg 2004; 77: 233– 237
  11. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM. Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 2008; 294: H402–408
  12. Opie LH. Ventricular function. In: Opie LH, editor. Heart Physiology from Cell to Circulation. 3rd ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 1998. pp. 343–389
  13. Date H, Imamura T, Onitsuka H, Maeno M, Watanabe R, Nishihira K, Matsuo T, Eto T. Diferential increase in natriuretic peptides in elite d